Filing Details
- Accession Number:
- 0000950170-24-125822
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-12 19:40:46
- Reporting Period:
- 2024-11-11
- Accepted Time:
- 2024-11-12 19:40:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1703647 | Korro Bio Inc. | KRRO | Pharmaceutical Preparations (2834) | 472324450 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1997973 | Vineet Agarwal | C/O Korro Bio, Inc. 60 First Street, 2Nd Floor, Suite 250 Cambridge MA 02141 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-11-11 | 800 | $11.68 | 800 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-11-11 | 800 | $70.00 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-11-11 | 800 | $0.00 | 800 | $11.68 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 30,807 | 2031-05-29 | No | 4 | M | Direct |
Footnotes
- The reported transactions occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 19, 2024.
- The shares subject to the option vest as to 25% of the shares on May 11, 2022, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
Billionaire Hedge Funds
